Active, not recruitingPhase 1NCT02869217

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Studying Gonadal germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Health Network, Toronto
Intervention
Cyclophosphamide(drug)
Enrollment
22 enrolled
Eligibility
16 years · All sexes
Timeline
2016 – 2026

Study locations (1)

Collaborators

Takara Bio Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02869217 on ClinicalTrials.gov

Other trials for Gonadal germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Gonadal germ cell tumor →

← Back to all trials